YourHouse 4.0 - Telepresence robots for the care and support of stroke patients

Phase 1

• Conditions: I63; I64; I69; I61; Cerebral infarction; Stroke, not specified as haemorrhage or infarction; Sequelae of cerebrovascular disease; Intracerebral haemorrhage

• Registration Number: DRKS00024846
• Lead Sponsor: Ostbayerische Technische Hochschule Regensburg RCHST - Regensburg Center of Health Sciences and Technology

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study Start: 2021-04-12
• Study Completion: 2023-12-31
• Results First Posted: 2024-04-27
• Last Update Posted: 19 August 2024

Recruitment & Eligibility

• Status: Complete
• Sex: All
• Target Recruitment: 42

Inclusion Criteria

Capacity to consent, post-acute and chronic phase, living in the home environment, sufficient knowledge of German.

Exclusion Criteria

Severe cognitive impairment, major depression; limitations that pose a significant barrier to the independent use of the telepresence robot and to the participation in the interventions: Severely reduced vision or limited visual field (hemianopsia); severe hypacusis without adequate hearing aid; severe neuropsychological deficits (attention deficits, executive dysfunction, memory deficits, neglect); severe motor action planning disorders (ideomotor or ideatory apraxia), severe limitations in communicative ability and language comprehension; severe motor limitations that prevent independent sitting or transfers.

Study & Design

• Study Type: interventional
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
The primary outcome of the intervention study is quality of life, assessed before and after the six-month intervention using the SAQOL-39 (Hilari et al., 2003). <br>The accompagnying research measures quality of life using the SS-QOL-12 (Post et al., 2010). Technology acceptance and willingness to use are investigated by a specially developed questionnaire.